Description Andrew York has over 30 years experience as a statistical programmer and biostatistician. From the beginning of his career as a statistician at Roche, to his current role as Clinical Data Science Vice President at Novo Nordisk, Andy has seen the industry evolve and has played a leading role in shaping best practice in the industry. Reflecting on these experiences, in this episode Andy shares his unique perspectives on the evolution of statistical programmers. Alongside this, Tomás and Andy discuss open-source programming, where the industry would be without standards, and the need for standards that are more sympathetic to AI and automation driven processes. Andy also explains why achieving full end-to-end traceability currently poses such a challenge, and why doing so has immense benefits to changing how we program studies today. In this conversation, we explore: The history of statistical programming and how the modern statistical programmer came to be Standards and their role in driving the industry forward Opportunities and challenges of open source programming Traceability and its potential in changing how we build and validate programs today The future of statistical programming and how AI will transform current ways of working 00:00 - Introduction to the Verisian Community Podcast 02:03 - The history of statistical programming and Andrew’s journey within the industry 12:19 - Where would the industry be without standards? 21:14 - Adoption of open source 36:07 - Building a computing environment 40:11 - How can traceability transform statistical programming? 52:06 - How AI will impact the future of statistical programming 01:09:25 - The changing role of a statistical programmer 1:12:14 - Rapid fire questions About The Verisian Community Podcast The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology. Resources Learn more about us: https://www.verisian.com/ Join the Verisian Community: https://www.verisian.com/community Follow us on LinkedIn: https://www.linkedin.com/company/verisian/ Listen on: Spotify: https://open.spotify.com/show/6EnSKNpv5ENwDTIElqRDxW Apple Podcasts: https://podcasts.apple.com/us/podcast/the-verisian-community-podcast/id1719471109

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related